Hypoxia-inducible factor 1α expression as an intrinsic marker of hypoxia: Correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix

Clinical Cancer Research

Volumn 10, Issue 24, 2004, Pages 8405-8412

  Hutchison, Gillian J ^a   Valentine, Helen R ^a   Loncaster, Juliette A ^a   Davidson, Susan E ^b   Hunter, Robert D ^b   Roberts, Stephen A ^a   Harris, Adrian L ^c   Stratford, Ian J ^a   Price, Patricia M ^a   West, Catharine M L ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PIMONIDAZOLE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SIZE; CANCER SURVIVAL; CELL HYPOXIA; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; UTERINE CERVIX CARCINOMA;

ANOXIA; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ION-SELECTIVE ELECTRODES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NITROIMIDAZOLES; OXYGEN; PROGNOSIS; RADIATION-SENSITIZING AGENTS; SURVIVAL RATE; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 19944429962     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0135     Document Type: Article

References (49)

1. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst (Bethesda) 2001;93:266-76.
2. Airley RE, Monaghan JE, Stratford IJ. Hypoxia and disease: oppurtunities for novel diagostic and therapeutic pro-drug strategies. Pharm J 2000;264:666-73.
3. Mottram J. A factor of importance in the radiosensitivity of tumours. Br J Radiol 1936;9:606-14.
4. Gopfert T, Gess B, Eckardt K, Kurtz A. Hypoxia signalling in the control of erythropoietin gene expression in rat hepatocytes. J Cell Physiol 1996;168:354-61.
5. Maxwell P, Dachs G, Gleadle J, et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 1997;94:8104-9.
6. Nakayama K, Kanzaki A, Hata K, et al. Hypoxia-inducible factor 1 alpha (HIF-1a) gene expression in human ovarian carcinoma. Cancer Lett 2002;176:215-23.
7. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998;95:7987-92.
8. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50.
9. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-9.
10. Brizel D, Scully S, Harrelson J. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-3.
11. Bussink J, Kaanders J, Strik A, Kogel A. v. d. Effects of nicotinamide and carbogen on oxygenation in human tumour xenografts measured with luminescence based fiber-optic probes. Radiother Oncol 2000;57:21-30.
12. Craighead PS, Pearcey R, Stuart G. A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2000;48:791-5.
13. Loncaster JA, Harris AL, Davidson SE, et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 2001;61:6394-9.
14. Airley R, Loncaster J, Davidson S, et al. Glucose transporter Glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 2001;7:928-34.
15. Airley RE, Loncaster J, Raleigh JA, et al. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer 2003;104:85-91.
16. nd ed. London: Springer Verlag; 1991.
17. Olapade-Olaopa E, Ogunbiyi J, MacKay E, et al. Further characterization of storage related alterations in immunoreactivity of archival tissue sections and its implications for collaborative multicenter immunohistochemical studies. Appl Immunohistochem Mol Morphol 2001;9:261-6.
18. Berthau P, Cazals-Hatem D, Meignin V, et al. Variability of immunohistochemical reactivity on stored paraffin slides. J Clin Pathol 1998;51:370-4.
19. West CML, Cooper RA, Loncaster JA, Wilks DP, Bromley M. Tumor vascularity: a histological measure of angiogenesis and hypoxia. Cancer Res 2001;61:2907-10.
20. Aebersold DM, Burri P, Beer KT, et al. Expression of hypoxia-inucible factor 1a: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001;61:2911-6.
21. Cooper RA, West CM, Logue JP, et al. Changes in oxygenation during radiotherapy in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1999;45:119-26.
22. Nordsmark M, Loncaster J, Chou S-C, et al. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. Int J Radiat Oncol Biol Phys 2001;49:581-6.
23. Raleigh J, Chou S-C, Bono E. Semi-quantitative immunohistochemical analysis for hypoxia in human tumours. Int J Radiat Oncol Biol Phys 2000;49:569-74.
24. Pastorek J, Pastorekova S, Callebaut I, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994;9:2877-88.
25. Davidson SE, West CM, Roberts SA, Hendry JH, Hunter RD. Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity. Radiother Oncol 1990;18:349-56.
26. Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 2001;85:881-90.
27. Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000;57:411-21.
28. Blancher C, Moore JW, Talks KL, Houlbrook S, Harris AL. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 2000;60:7106-13.
29. Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002;53:1192-202.
30. Koukourakis MI, Giatromanolaki A, Skarlatos J, et al. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 2001;61:1830-2.
31. Birner P, Schindl M, Obermair A, et al. Overexpression of hypoxia-inducible factor 1a is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000;60:4693-6.
32. Haugland HK, Vukovic V, Pintilie M, et al. Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation. Int J Radiat Oncol Biol Phys 2002;53:854-61.
33. Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 1997;272:22642-7.
34. Zhong H, Chiles K, Feldser D, et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000;60:1541-5.
35. Kaluz S, Kaluzova M, Chrastina A, et al. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1alpha stabilization: a role for phosphatidylinositol 3′-kinase. Cancer Res 2002;62:4469-77.
36. Jiang B-H, Jiang C, Zheng J, et al. Phosphatidylinositol 3-kinase signalling controls levels of hypoxia-inducible factor 1. Cell Growth Differ 2001;12:363-9.
37. Sandau KB, Fandrey J, Brune B. Accumulation of HIF-1a under the influence of nitric oxide. Blood 2001;97:1009-15.
38. Minchenko A, Caro J. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: a role of the hypoxia responsive element. Mol Cell Biochem 2000;208:53-62.
39. Hui EP, Chan ATC, Pezzella F, et al. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res 2002;8:2595-604.
40. Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 2001;61:7992-8.
41. Wykoff CC, Beasley NJ, Watson PH, et al. Hypoxia-inducible expression of tumor associated carbonic anhydrases. Cancer Res 2000;60:7075-83.
42. Bachtiary B, Schindl M, Potter R, et al. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res 2003;9:2234-40.
43. Burri P, Djonov V, Aebersold DM, et al. Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:494-501.
44. Schindl M, Schoppmann S, Samonigg H, et al. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node positive breast cancer. Clin Cancer Res 2002;8:1831-7.
45. Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI. Association of hypoxia-inducible factors 1a and 2a with activated angigenic pathways and prognosis in patients with endometrial carcinoma. Cancer (Phila) 2002;95:1055-63.
46. Kaanders JH, Wijffels KI, Marres HA, et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 2002;62:7066-74.
47. Loncaster JA, Carrington BM, Sykes JR, et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;54:759-67.
48. Swinson D, Jones J, Cox G, et al. Hypoxia inducible factor (HIF)-1a in non-small cell lung cancer (NSCLC). Br J Cancer 2002;86:S28.
49. Maxwell PH. Oxygen homeostasis and cancer: insights from a rare disease. Clin Med 2002;2:356-62.